Vertebrobasilar Artery Syndrome Treatment Market Trends

Growth Drivers

• Growing Chance of Developing Atherosclerosis – Atherosclerosis is a condition where cholesterol, fat, blood cells, and other substances in the blood form plaques. As a result of the formation of plaques, the arteries tend to become narrow and subsequently reduce the supply of oxygen-rich blood to tissues to the vital organs in the body. It has been stated that atherosclerosis could also lead to vertebrobasilar artery syndrome and aid in bringing lucrative growth opportunities for the global market growth during the forecast period. According to the recent statistics of 2022, it has been stated that the prevalence of atherosclerosis is among almost 50% of Americans who are over 50 years.
• Increasing Rate of Artery-Related Diseases – Artery diseases are caused by plaque buildup in the wall of the arteries that supply blood to body organs. A plaque is a consequence of cholesterol deposits over time which causes the inside of the arteries to narrow. Thus, people diagnosed with artery diseases are estimated to generate the need for vertebrobasilar artery syndrome treatment in the upcoming years. This factor is estimated to create a positive outlook for market growth in the assessment period. According to the statistics from the National Library of Medicine, it is been revealed that coronary artery disease (CAD) is considered to be the third leading cause of mortality, accounting for almost 17.8 million deaths annually across the world.
• The Surge in Lifestyle Disorders and Illnesses – In the recent period, people have been diagnosed with lifestyle diseases owing to the adoption of a sedentary lifestyle and consumption of fast food. As a result, the rate of cholesterol, diabetes, stress, and other illnesses increased considerably leading to the development of vertebrobasilar artery syndrome and ultimately vertebrobasilar artery syndrome treatment for cure. The latest data suggests from the World Health Organization stated that raised cholesterol is estimated to cause 2.6 million deaths and 29.7 million DALYs in the world.
• Increasing Investment in Healthcare Sector with Rising Healthcare Expenditure - The overall health expenditure in the U.S. rose beyond USD 4 trillion in 2020. Moreover, expenditure as a percentage of GDP is anticipated to rise by about 20% by the year 2028.
• Burgeoning Geriatric Population Across the World - According to the United Nations, the number of people aged 65 years and older is projected to more than double by the year 2050, reaching 1.5 billion globally.

Challenges

• High Cost of Vertebrobasilar Artery Syndrome Treatment – The treatment of vertebrobasilar artery syndrome requires advanced technologies and medical products. As a result, the treatment of vertebrobasilar artery syndrome costs high and requires a huge amount of money. As a result, the adoption rate of vertebrobasilar artery syndrome treatment is expected to lower among the population with low and middle income. This factor is subsequently expected to hamper the growth of the global vertebrobasilar artery syndrome market during the forecast period.
• The Dearth of Skilled Professionals
• Lack of Reimbursement